259
Views
12
CrossRef citations to date
0
Altmetric
Articles

Synthesis and antitumor activity of tetrandrine derivatives

, , , &
Pages 993-1002 | Received 28 Mar 2013, Accepted 08 Jul 2013, Published online: 14 Aug 2013
 

Abstract

Tetrandrine possesses antitumor activity, however, only a few studies on its structure modification were reported. To improve the antitumor activity of tetrandrine, 20 new tetrandrine derivatives were designed and synthesized by Sonogashira and Suzuki reactions. Their antitumor activities were evaluated against three tumor cell lines including A549, HepG2, and BGC-823 by methyl thiazolyl tetrazolium assay with taxol as a positive control. The results showed that compounds 2c and 2g were highly potent against BGC-823 cell line, and compounds 1i and 1k showed particular activity against HepG2 cells. These results demonstrated that compounds 1i, 1k, 2c, and 2g were promising leads for further investigation.

Acknowledgements

The authors would like to express their sincere appreciations to Prof. Jian-Xin Li, School of Chemistry & Chemical Engineering, Nanjing University, China for his technical direction in the synthesis of the compounds.

This project was supported by the 11th Five Plan for Major Scientific and Technological Specialized Project for Significant Formulation of New Drugs (No. 2009ZX09301-007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.